eISSN: 2345-6558

Free Access

Journal of Parathyroid Disease 2018;6(2):36-38 doi: 10.15171/jpd.2018.14
The need for a reliable bone biomarker to better assess chronic kidney disease mineral and bone disorder

Review

Ramin Tolouian 1 * , Ajay Gupta 2

1 Department of Internal Medicine, Manatee Memorial Hospital, Bradenton, FL, USA.
2 Rockwell Medical, Wixom, MI, USA.


*Corresponding author: Ramin Tolouian,
Email: Tolouian@yahoo.com


Abstract
Chronic kidney disease mineral and bone disorder is a metabolic bone disease present in almost all uremic patients. There are no good markers of bone resorption available for uremic patients. The validity of parathormone as a surrogate marker of bone and mineral disorders has been questioned over the past decade. We need to shift from Surrogate markers to bone markers.


Comments
First name  
Last name  
Email address  
Comments  
Security code



Article
PDF


Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks

Cite by
Google Scholar

Google Scholar
Articles by Ramin Tolouian
Articles by Ajay Gupta
Similar articles
Related articles

PubMed
Articles by Ramin Tolouian
Articles by Ajay Gupta


Article Access Statistics
Viewed
PDF Downloaded
Comments

Share this article!
Creative Commons Attribution 4.0 License This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 The Author(s)
Published by Nickan Research Institute